Financial Performance. Cigna has demonstrated resilience in its financial performance, with analysts projecting solid earnings growth. For the fiscal year 2025, earnings per share (EPS) estimates ...

This performance was primarily driven by its Cigna Healthcare segment, supported by a healthy free cash flow yield of 7% and an attractive P/E ratio of 17.35 relative to its growth prospects.

With an expected EPS of $28.94 for FY2025 and a current P/E ratio of 26.3x, InvestingPro analysis reveals 12 additional key insights about Cigna’s growth prospects and market position.

In this update, I share my view on Cigna's performance in 2023 ... A similar picture emerges when CI stock is valued using a discounted cash flow analysis. With a current baseline free cash ...

Cigna (NYSE:CI) has had a great run on the share market with its stock up by a significant 14% over the last three months. Given the company's impressive performance, we decided to study its ...

Cigna (CI) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

In the latest market close, Cigna (CI) reached $292.07, with a +0.54% movement compared to the previous day. The stock outpaced the S&P 500's daily gain of 0.45%.

Cigna stock gets a Buy rating today. Strengths: dividends, valuation, revenue growth, net income & EPS, share price vs. moving average, capital & liquidity. Offsetting factors: price performance ...

Cigna Group closed 14.95% below its 52-week high of $370.83, which the company reached on September 16th.

Cigna Corporation (NYSE ... Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and exclusive insights on CI. Our Pro platform offers fair value estimates, performance ...

Cigna Corporation (NYSE:CI), a global health service organization with a market capitalization of $87 billion, has been navigating a complex landscape of market shifts, regulatory changes, and ...